The Rapid-Start Program provides pharmaceutical developers with a quick and cost-effective solution for determining the feasibility of using Activ-Blister™ solutions to solve their oral solid dose drug stability challenges.
Why Rapid-Start Program?
- Accelerates time-to-market and de-risks drug product development
- Enables a low cost solution to determine feasibility of your drug product using Activ-Blister™ solutions
- Fast sample production with Activ-Blister™ samples delivered in as little as 4 weeks
- Streamlined specifications simplify the process of selecting the right solution for your drug product
